Gemtesa
Payments companies reported to CMS as associated with Gemtesa. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Gemtesa, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Gemtesa
These are the largest totals companies reported as associated with Gemtesa. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Matt Rosenberg | Jackson, MI | Family Medicine | $184,597.18 |
| David Staskin | Brighton, MA | Urology | $145,061.55 |
| Michael Kennelly | Charlotte, NC | Urology | $129,573.63 |
| Ashley Tapscott | Nashville, TN | Urology | $102,033.06 |
| Jeffrey Frankel | Burien, WA | $96,972.89 | |
| Nathaniel Barnes | Webster, TX | Urology | $90,326.99 |
| Diane Newman | Philadelphia, PA | Adult Health (Nurse Practitioner) | $85,558.30 |
| Scott Macdiarmid | Greensboro, NC | Urology | $84,855.08 |
| Shenelle Wilson | Kingsport, TN | Urology | $83,206.55 |
| Benjamin Brucker | New York, NY | Urology | $82,989.34 |
Prescribed Gemtesa?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.